Drugs / FOSDEVIRINE
FOSDEVIRINE
Trials 11 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 18 trials | ||||||
| Phase 1 | NCT01283100 | Mar 2011 | HIV infectious disease | ViiV Healthcare | Withdrawn | No outcome recorded |
| Phase 1 | NCT01273103 | Jan → Feb 2011 | HIV infectious disease | ViiV Healthcare | Withdrawn | No outcome recorded |
| Phase 1 | NCT01195974 | Sep 2010 → Feb 2011 | HIV infectious disease | ViiV Healthcare | Terminated | No outcome recorded |
| Phase 1 | NCT01209117 | Sep 2010 → Jan 2011 | HIV infectious disease, Herpesviridae infectious disease | ViiV Healthcare | Completed | No outcome recorded |
| Phase 1 | NCT01138072 | Jun → Aug 2010 | HIV infectious disease | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT01101893 | Apr → Jun 2010 | HIV infectious disease | ViiV Healthcare | Completed | No outcome recorded |
| Phase 1 | NCT01031472 | Dec 2009 → Mar 2010 | HIV infectious disease | ViiV Healthcare | Completed | No outcome recorded |
| Phase 1 | NCT00920088 | Jun → Nov 2009 | HIV infectious disease | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT01231555 | Nov 2010 → Jul 2011 | HIV infectious disease | ViiV Healthcare | Terminated | No outcome recorded |
| Phase 2 | NCT01199731 | Oct 2010 → Jul 2011 | HIV infectious disease | ViiV Healthcare | Terminated | No outcome recorded |
| Phase 2 | NCT00945282 | Oct → Nov 2009 | HIV infectious disease | ViiV Healthcare | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 13 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FOSDEVIRINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104968 ↗ |
| Known as | Fosdevirina | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104968 ↗ |
| Known as | GSK 2248761A | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104968 ↗ |
| Known as | GSK2248761 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01283100 ↗ |
| Known as | IDX-899 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104968 ↗ |
| Action | Inhibit | “next generation non-nucleoside reverse transcriptase inhibitor GSK2248761” PMID 22288567 ↗ Aug 2012 |
| Modality | Small molecule | “next generation non-nucleoside reverse transcriptase inhibitor GSK2248761” PMID 22288567 ↗ Aug 2012 |
| Route | Oral | “Once Daily Oral Dose of GSK2248761” NCT01199731 ↗ |